Factors that contributed to black-white disparities in survival among nonelderly women with breast cancer between 2004 and 2013

Journal of Clinical Oncology

Volumn 36, Issue 1, 2018, Pages 14-24

  Jemal, Ahmedin ^a   Robbins, Anthony S ^a   Lin, Chun Chieh ^a   Flanders, W Dana ^b   DeSantis, Carol E ^a   Ward, Elizabeth M ^a   Freedman, Rachel A ^c  

^a AMERICAN CANCER SOCIETY   (United States)

^b EMORY UNIVERSITY   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALL CAUSE MORTALITY; BLACK PERSON; BREAST CANCER; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CAUSE OF DEATH; COMORBIDITY; EARLY CANCER; ETHNICITY; FEMALE; FOLLOW UP; HEALTH DISPARITY; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE; REVIEW; RISK FACTOR; SURVIVAL TIME; ADOLESCENT; AFRICAN AMERICAN; BREAST TUMOR; ETHNOLOGY; HEALTH CARE DISPARITY; KAPLAN MEIER METHOD; METABOLISM; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

STEROID RECEPTOR;

ADOLESCENT; ADULT; AFRICAN AMERICANS; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; INSURANCE, HEALTH; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RECEPTORS, STEROID; UNITED STATES; YOUNG ADULT;

EID: 85039918668     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2017.73.7932     Document Type: Review

References (62)

1. De Santis CE, Fedewa SA, Goding Sauer A, et al: Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin 66:31-42, 2016.
2. Jatoi I, Anderson WF, Rao SR, et al: Breast cancer trends among black and white women in the United States. J Clin Oncol 23:7836-7841, 2005.
3. Siegel RL, Miller KD, Jemal A: Cancer Statistics, 2017. CA Cancer J Clin 67:7-30, 2017.
4. van Ravesteyn NT, Schechter CB, Near AM, et al: Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States. Cancer Epidemiol Biomarkers Prev 20:112-122, 2011.
5. Menashe I, Anderson WF, Jatoi I, et al: Underlying causes of the black-white racial disparity in breast cancer mortality: A population-based analysis. J Natl Cancer Inst 101:993-1000, 2009.
6. Hunt BR, Whitman S, Hurlbert MS: Increasing black-white disparities in breast cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol 38:118-123, 2014.
7. Curtis E, Quale C, Haggstrom D, et al: Racial and ethnic differences in breast cancer survival: How much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 112:171-180, 2008.
8. Bickell NA, Wang JJ, Oluwole S, et al: Missed opportunities: Racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24:1357-1362, 2006.
9. Shavers VL, Brown ML: Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94:334-357, 2002.
10. Silber JH, Rosenbaum PR, Clark AS, et al: Characteristics associated with differences in survival among black and white women with breast cancer. JAMA 310:389-397, 2013.
11. Iqbal J, Ginsburg O, Rochon PA, et al: Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA 313:165-173, 2015.
12. Mohanty S, Bilimoria KY: Comparing national cancer registries: The National Cancer Data Base (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) program. J Surg Oncol 109:629-630, 2014.
13. Stewart AK, Bland KI, McGinnis LS Jr, et al: Clinical highlights from the National Cancer Data Base, 2000. CA Cancer J Clin 50:171-183, 2000.
14. Greene FL, Page D, Fleming I, et al: AJCC Cancer Staging Manual (ed 6). New York, NY, Springer-Verlag, 2002.
15. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-619, 1992.
16. Hansen BB, Fredrickson M, Buckner J, et al: Matching in R using the optmatch and RItools packages, 2016. https://cran.r-project.org/web/packages/optmatch/vignettes/fullmatch-vignette.pdf.
17. Austin PC: Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28:3083-3107, 2009.
18. Rosenbaum PR, Silber JH: Using the exterior match to compare two entwined matched control groups. Am Stat 67:67-75, 2013.
19. Tehranifar P, Neugut AI, Phelan JC, et al: Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev 18:2701-2708, 2009.
20. Ward E, Halpern M, Schrag N, et al: Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58:9-31, 2008.
21. Roberts MC, Wheeler SB, Reeder-Hayes K: Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: A systematic review. Am J Public Health 105(Suppl 3): E4-e15, 2015.
22. Hershman DL, Tsui J, Wright JD, et al: Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. J Clin Oncol 33:1053-1059, 2015.
23. Freedman RA, Hughes ME, Ottesen RA, et al: Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network. Cancer 119:839-846, 2013.
24. Freedman RA, Virgo KS, He Y, et al: The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer 117:180-189, 2011.
25. Dignam JJ: Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin 50:50-64, 2000.
26. Dignam JJ: Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women. J Natl Cancer Inst Monogr 30: 36-43, 2001.
27. Dignam JJ, Redmond CK, Fisher B, et al: Prognosis among African-American women and white women with lymph node negative breast carcinoma: Findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). Cancer 80:80-90, 1997.
28. Yood MU, Johnson CC, Blount A, et al: Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst 91: 1487-1491, 1999.
29. Albain KS, Unger JM, Crowley JJ, et al: Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 101:984-992, 2009.
30. Hershman DL, Unger JM, Barlow WE, et al: Treatment quality and outcomes of African American versus white breast cancer patients: Retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol 27:2157-2162, 2009.
31. Reeder-Hayes K, Peacock Hinton S, Meng K, et al: Disparities in use of human epidermal growth hormone receptor 2-Targeted therapy for early-stage breast cancer. J Clin Oncol 34:2003-2009, 2016.
32. Rosenberg PS, Menashe I, Jatoi I, et al: Re: Racial disparities in cancer survival among randomized clinical trials of the Southwest Oncology Group. J Natl Cancer Inst 102:277, 2010.
33. Tammemagi CM, Nerenz D, Neslund-Dudas C, et al: Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294:1765-1772, 2005.
34. Hershman D, Weinberg M, Rosner Z, et al: Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst 95: 1545-1548, 2003.
35. Griggs JJ, Sorbero ME, Stark AT, et al: Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 81:21-31, 2003.
36. Griggs JJ, Culakova E, Sorbero ME, et al: Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens. J Clin Oncol 25:2522-2527, 2007.
37. Oeffinger KC, Fontham ET, Etzioni R, et al: Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 314:1599-1614, 2015.
38. Blackman DK, Bennett EM, Miller DS: Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997): Behavioral risk factor surveillance system. MMWR CDC Surveill Summ 48:1-22, 1999.
39. Ryerson AB, Miller JW, Eheman CR, et al: Recent trends in U.S. mammography use from 2000- 2006: A population-based analysis. Prev Med 47: 477-482, 2008.
40. Sabatino SA, Coates RJ, Uhler RJ, et al: Disparities in mammography use among US women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Med Care 46:692-700, 2008.
41. Allgood KL, Rauscher GH, Whitman S, et al: Validating self-reported mammography use in vulnerable communities: Findings and recommendations. Cancer Epidemiol Biomarkers Prev 23: 1649-1658, 2014.
42. Cronin KA, Miglioretti DL, Krapcho M, et al: Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev 18:1699-1705, 2009.
43. Rauscher GH, Johnson TP, Cho YI, et al: Accuracy of self-reported cancer-screening histories: A meta-Analysis. Cancer Epidemiol Biomarkers Prev 17:748-757, 2008.
44. Rauscher GH, Conant EF, Khan JA, et al: Mammogramimage quality as a potential contributor to disparities in breast cancer stage at diagnosis: An observational study. BMC Cancer 13:208, 2013.
45. Smith-Bindman R, Miglioretti DL, Lurie N, et al: Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 144:541-553, 2006.
46. Gorin SS, Heck JE, Cheng B, et al: Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166:2244-2252, 2006.
47. Gwyn K, Bondy ML, Cohen DS, et al: Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 100: 1595-1604, 2004.
48. Ansell D, Grabler P, Whitman S, et al: A community effort to reduce the black/white breast cancer mortality disparity in Chicago. Cancer Causes Control 20:1681-1688, 2009.
49. Press R, Carrasquillo O, Sciacca RR, et al: Racial/ethnic disparities in time to follow-up after an abnormal mammogram. J Womens Health (Larchmt) 17:923-930, 2008.
50. Fedewa SA, Ward EM, Stewart AK, et al: Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: A national cohort study, 2004-2006. J Clin Oncol 28:4135-4141, 2010.
51. Bickell NA, Chassin MR: Determining the quality of breast cancer care: Do tumor registries measure up? Ann Intern Med 132:705-710, 2000.
52. Cress RD, Zaslavsky AM, West DW, et al: Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care 41:1006-1012, 2003.
53. Doebbeling BN, Wyant DK, McCoy KD, et al: Linked insurance-Tumor registry database for health services research. Med Care 37:1105-1115, 1999.
54. Du XL, Key CR, Dickie L, et al: Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews. J Clin Epidemiol 59:53-60, 2006.
55. Malin JL, Kahn KL, Adams J, et al: Validity of cancer registry data formeasuring the quality of breast cancer care. J Natl Cancer Inst 94:835-844, 2002.
56. Mallin K, Palis BE, Watroba N, et al: Completeness of American cancer registry treatment data: Implications for quality of care research. J Am Coll Surg 216:428-437, 2013.
57. Howlader N, Altekruse SF, Li CI, et al: US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 106:dju055, 2014.
58. National Cancer Institute Surveillance, Epidemiology, and End Results Program: Www.seer.
59. Flanders WD, Eldridge RC, McClellan W: A nearly unavoidable mechanism for collider bias with index-event studies. Epidemiology 25:762-764, 2014.
60. Greenland S, Pearl J: Casual Diagrams, in LovricM(ed): International Encyclopedia of Statistical Science. Berlin, Springer-Verlag, 2011, p 208.
61. Dahabreh IJ, Kent DM: Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA 305:822-823, 2011.
62. Buchmueller TC, Levinson ZM, Levy HG, et al: Effect of the Affordable Care Act on racial and ethnic disparities in health insurance coverage. Am J Public Health 106:1416-1421, 2016.